Hua Medicine (Shanghai) Ltd. Stock OTC Markets
Equities
HUMDF
KYG4644K1022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2028 USD | -54.93% | -.--% | -.--% |
03-28 | Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024 | CI |
Sales 2023 | 76.61M 10.59M 14.42M | Sales 2024 * | - | Capitalization | 1.42B 197M 268M |
---|---|---|---|---|---|
Net income 2023 | -211M -29.18M -39.72M | Net income 2024 * | - | EV / Sales 2023 | 22.9 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | - |
P/E ratio 2023 |
-8.14
x | P/E ratio 2024 * |
-
| Employees | 177 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.36% |
Latest transcript on Hua Medicine (Shanghai) Ltd.
1 day | -54.93% |
Managers | Title | Age | Since |
---|---|---|---|
Li Chen
FOU | Founder | 61 | 09-11-09 |
Li Changhong
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Di Hong
COO | Chief Operating Officer | 45 | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Nelsen
CHM | Chairman | 60 | 10-04-22 |
William Keller
BRD | Director/Board Member | 75 | - |
Yiu Wa Tsui
BRD | Director/Board Member | 74 | 18-08-31 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-2.30% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- 2552 Stock
- HUMDF Stock